The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,621,698 in first-year total cost, median $319,726.
Most frequent study sections
- Special Emphasis Panel[ZRG1 BST-R (10)]2
- Special Emphasis Panel[ZRG1 HDM-K (11)]1
- Special Emphasis Panel[ZRG1 OTC-D (13)]1
- Special Emphasis Panel[ZRG1 SBIB-G (11)]1
Most frequent institutions
- 5M BIOMED, LLC1
- CAPSULOMICS, LLC1
- CYTOASTRA, LLC1
- GLYCIOME, LLC1
- ITRUNSINMYFAMILY.COM, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Diagnosis of Esophageal Squamous Cell Carcinoma in Low-Income Countries1R41CA261376-01A1 | LUNZ, DANIEL GREGORY | CAPSULOMICS, LLC, MD | $399,995 | ZRG1 |
| 2021 | Cervical Cancer Prevention Prebiotic Device1R41CA254543-01A1 | ELLINGTON, JOANNA ELIZABETHFICHOROVA, RAINA N. | GLYCIOME, LLC, WA | $399,993 | ZRG1 |
| 2020 | Serum Detection of Medulloblastoma Metastasis1R41CA254744-01 | LI, YUANCHENGMAO, HUI | 5M BIOMED, LLC, GA | $319,726 | ZRG1 |
| 2020 | Clinical Cytophone platform for detection of circulating melanoma cells.1R41CA247027-01A1 | MAKHOUL, ISSAMSUEN, JAMES | CYTOASTRA, LLC, AR | $201,984 | ZRG1 |
| 2019 | Identifying hereditary cancer patients in low-resource community cancer settings using an innovative informatics solution1R41CA239867-01A1 | HUGHES-HALBERT, CHANITA A.WELCH, BRANDON M | ITRUNSINMYFAMILY.COM, INC., SC | $300,000 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.